Jonathan Biller
Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
Affiliation history
Recorded current and former roles; source labels appear when available.
-
Current
2020-09-11–present
-
Agios Pharmaceuticals, Inc. (AGIO)
Proxy statement
Current -
Start not stated–2022-09-16
Company network
Recorded roles and earnings-call appearances connecting this person to public companies.
Executive compensation
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2022 | Agios Pharmaceuticals, Inc. (AGIO) | Former Chief Financial Officer, Head of Corporate Affairs | $388,850 | $1,478,067 |
| 2021 | Agios Pharmaceuticals, Inc. (AGIO) | Former Chief Financial Officer, Head of Corporate Affairs | $530,140 | $2,832,035 |
| 2020 | Agios Pharmaceuticals, Inc. (AGIO) | Former Chief Financial Officer, Head of Corporate Affairs | $500,000 | $769,328 |
| 2019 | Agios Pharmaceuticals, Inc. (AGIO) | Chief Financial Officer, Head of CorporateAffairs | $39,583 | $3,183,889 |
| 2018 | Agios Pharmaceuticals, Inc. (AGIO) | Chief Legal Officer | — | — |
| 2017 | Agios Pharmaceuticals, Inc. (AGIO) | Chief Financial Officer, Head of Legal andCorporate Affairs | — | — |
Recent activity
Earnings-call appearances and filed executive appointments or departures, newest first.